MedMeetings – Translate Knowledge Into the Practice

EASD 2024

Is Semaglutide as Effective at Reducing Major Cardiovascular Events in the Presence of Impaired Kidney Function in People with Overweight or Obesity? A Prespecified Analysis from the SELECT Trial

This trial was presented by Dr Helen Colhoun (United Kingdom)

Mukul Ayachit March 27, 2025

EASD 2024

Exploring HLA Genotype Variations in Type 1 Diabetes: Implications for Precision Medicine and Immunotherapy Response

This study was presented by Drs Ulf Hannelius (Sweden) at

Mukul Ayachit March 26, 2025

EASD 2024

Albuminuria Trajectories Over Six Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

This trial was presented by Dr Wendy Davis (Australia) at

Mukul Ayachit March 25, 2025

EASD 2024

Redefining the eGFRAlbuminuria Relationship Using Genetics: Setting Stage for Precision Monitoring

This session was presented by Dr Cilia H Naaman (Denmark)

Mukul Ayachit March 24, 2025

EASD 2024

Blocking the Effects of Endogenous GIP Increases Fasting Plasma Glucose Levels in Individuals with Obesity

This study was presented by Drs Mads Helsted, Frederikke Koefoed-Hansen

Mukul Ayachit March 21, 2025

EADV 2024

The Role of HPV, Prognostication, Adjuvant Radiotherapy, And High-Risk Patient Staging and Follow-Up in SCC

In a study at the 33rd EADV Congress 2024, on

Mukul Ayachit March 20, 2025

Latest Articles

Societies

Speciality